Poor drug safety controls may trigger another PPA scandal.

Rep. Ahn Myeong-ok of the National Assembly, Health and Welfare Committee said in the KFDA report on April 19 that some drugs including levosulpiride that were not approved or prohibited to sell in the advanced countries such as the U. S. and Canada are commonly available in the Korean markets.

She also said that a similar product like cisapride was withdrawn from the market due to its adver...